{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-24-005928","form_type":"8-K","ticker":"EDSA","cik":"0001540159","company_name":"Edesa Biotech, Inc.","filed_at":"2024-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.746077+00:00","generated_at":"2026-05-30T07:24:53.532939+00:00","sec_items":["1.01","5.03","1.02","2.03","3.02","3.03","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Edesa Biotech enters $5M securities purchase agreement with CEO; $1.54M immediate investment","bullets":["CEO-affiliated entity invests $1,540,819 for 150 Series A-1 Preferred Shares ($10K stated value) and warrants at $3.445 conversion/exercise price.","Preferred shares convertible into 435,414 common shares; warrants cover 326,560 common shares (75% of conversion shares).","Up to $5M total investment possible; purchases over $2M require shareholder approval under Canadian law.","$10M revolving credit facility with same entity terminated; no funds drawn and no termination penalties.","Securities issued in private placement exempt from registration; subject to Canadian hold periods."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-24-005928","json":"https://secwatch.observer/filing/0001171843-24-005928.json","markdown":"https://secwatch.observer/filing/0001171843-24-005928.md","text":"https://secwatch.observer/filing/0001171843-24-005928.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1540159/000117184324005928/0001171843-24-005928-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1540159/000117184324005928/f8k_103024.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T07:24:53.532939+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}